Assoc Prof Peter Grimison
MBBS (Hons) MPH PhD FRACP
Phone: (02) 8514 0151
Fax: (02) 9383 1014
Peter Grimison is a Staff Specialist in Medical Oncology at the Chris O’Brien Lifehouse in Sydney, Visiting Medical Officer at Royal Prince Alfred Hospital, and Clinical Associate Professor at the University of Sydney. His clinical work focuses on testicular cancer, other genito-urinary cancers, and upper gastro-intestinal cancers. He serves as a member of the Australian Government Pharmaceutical Benefits Advisory Committee, and a number of other Federal and NSW Government committees. He is also committed to teaching as coordinator of Advanced Training in Medical Oncology at the Chris O’Brien Lifehouse, and also actively teaches in Basic Physician Training and the University of Sydney Medical Program.
Phone: (02) 8514 0151
Fax: (02) 9383 1014
Special Interests / Areas of Research
Peter’s research interests incorporate clinical research about genito-urinary and upper gastro-intestinal cancers, oncology health services research, and quality of life assessment in clinical trials (PhD completed). He is involved as germ cell subcommittee chair, study chair, member of the scientific advisory committee, trial management committee member, and site principal investigator in several national and international trials for the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), whose coordinating centre is based at the NHMRC Clinical Trials Centre of the University of Sydney. He is the study chair for the world’s largest trial of medicinal cannabis for the control of chemotherapy-induced nausea and vomiting. He is also actively involved in phase I, II, and III clinical trials for the Australasian Gastro-Intestinal Trials Group and industry sponsors.
Q&A with Assoc Prof Peter Grimison
Clinical Associate Professor Peter Grimison
I have a Bachelor of Science, Medicine and Surgery; a Masters in Public Health; a Doctor of Philosophy in Cancer Clinical Trials and Quality of Life; and am a fellow of the Royal Australasian College of Physicians with specialist qualifications in Medical Oncology.
Delivering pamphlets on my bicycle at age 11.
I am a cancer specialist who focusses on prescribing chemotherapy and other “systemic” treatments, and a cancer researcher who is active in clinical trials of new cancer therapies.
It is a privilege to be so involved in the lives of patients and their relatives at such a critical point in their lives. I also love working with trainee doctors, who are not only incredibly bright and keen to learn but also have a habit of asking curly questions which makes sure you keep on top of the latest knowledge.
Since it opened.
It is an amazing centre of excellence in cancer care and research, that has the welfare of patients as the first priority.
To lead national and international clinical trials of new treatments that could reduce deaths of young men suffering from aggressive forms of testicular cancer, and a cannabis medicine that could relieve nausea and vomiting due to chemotherapy.
Get some rest so as to get up at 5 a.m. to go cycling along the Eastern Suburbs Hills beaches or across to Mosman with my cycling club.
I assess a patient who usually has already been diagnosed with cancer, discuss prognosis and treatment options, prescribe chemotherapy and other “systemic” treatments with the aim of curing patients or at least improving their quality of life and life expectancy, and help to coordinate other treatments such as surgery and radiotherapy and palliative care.
Medical Oncology offers an inspiring combination of developing close relationships with patients, the challenge of managing complex and potentially critical illnesses, working with an interdisciplinary team rather than in isolation, and a sharp focus on cutting-edge research and clinical trials.
Working in an interdisciplinary team is crucial in such a complex field as cancer. It is immensely satisfying to work with such a skilled group of colleagues including other medical and radiation oncologists, surgeons, nurses, allied health staff and researchers.